Published in Diabetes Metab on February 22, 2007
Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. Dev Cell (2009) 1.40
Expression Profiling of Genes Related to Endothelial Cells Biology in Patients with Type 2 Diabetes and Patients with Prediabetes. Biomed Res Int (2016) 1.39
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels (2007) 1.05
Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study. BMC Med Genomics (2010) 0.98
Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling. PLoS One (2011) 0.94
Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine (2010) 0.94
Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats. PLoS One (2012) 0.93
Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice. Endocrinology (2011) 0.90
Potential role of increased matrix metalloproteinase-2 (MMP2) transcription in impaired adipogenesis in type 2 diabetes mellitus. Biochem Biophys Res Commun (2008) 0.90
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus. Hypertens Res (2015) 0.88
Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes. PLoS One (2013) 0.87
Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia. Arch Med Sci (2011) 0.86
Tissue Factor, Tissue Factor Pathway Inhibitor and Factor VII Activity in Cardiovascular Complicated Type 2 Diabetes Mellitus. Oman Med J (2010) 0.86
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus. BMC Cardiovasc Disord (2016) 0.84
Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis. Vasc Health Risk Manag (2007) 0.82
Clinical, microbiological, and salivary biomarker profiles of dental implant patients with type 2 diabetes. Clin Oral Implants Res (2013) 0.78
Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II. Arch Med Sci (2015) 0.78
Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes. Graefes Arch Clin Exp Ophthalmol (2012) 0.78
Significance of impaired serum gelatinases activities in metabolic syndrome. Toxicol Int (2014) 0.77
Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D). Sci Rep (2016) 0.75
Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes. Int J Mol Sci (2016) 0.75
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch. Sci Rep (2016) 0.75
Causality relationships between coagulation factors in type 2 diabetes mellitus: path analysis approach. Med J Islam Repub Iran (2014) 0.75
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus. Vasc Health Risk Manag (2016) 0.75
MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study. Biomed Res Int (2017) 0.75
Association studies of genetic polymorphisms and complex disease. Lancet (2000) 4.37
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest (1987) 3.29
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation (1999) 2.90
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes Metab (2012) 2.44
Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1996) 2.31
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes Obes Metab (2012) 2.23
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med (2005) 2.10
Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med (1998) 2.03
Central diabetes insipidus in children and young adults. N Engl J Med (2000) 1.97
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia. Atherosclerosis (1999) 1.94
Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab (2004) 1.94
Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost (2014) 1.91
Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med (1998) 1.90
Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int (1982) 1.83
ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med (2011) 1.75
Obesity and insulin resistance in humans: a dose-response study. Metabolism (1990) 1.74
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients. Ann Oncol (2010) 1.73
Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results. Nutr Metab Cardiovasc Dis (2012) 1.73
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia (2005) 1.71
Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med (1995) 1.70
Headache attributed to infection: observations on the IHS classification (ICHD-II). Cephalalgia (2006) 1.69
A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia (2012) 1.63
Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment. Eye (Lond) (2012) 1.60
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients. Eur J Clin Invest (2001) 1.54
The role of functional respiratory tests in predicting pneumothorax during lung needle biopsy. Chest (1996) 1.52
Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid. Eur J Clin Invest (2008) 1.52
Risk for renal failure in nephrolithiasis. Am J Kidney Dis (2001) 1.50
Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med (1986) 1.49
Control of SIV rebound through structured treatment interruptions during early infection. Science (2000) 1.48
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med (2008) 1.46
Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr (1998) 1.45
Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery. Cochrane Database Syst Rev (2003) 1.44
Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica (1999) 1.43
Road transportation affects blood hormone levels and lymphocyte glucocorticoid and beta-adrenergic receptor concentrations in calves. Vet J (2004) 1.43
UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen. Oncology (2008) 1.43
Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis. Ital J Gastroenterol Hepatol (1997) 1.39
Is the red cell morphology really useful to detect the source of hematuria? Am J Nephrol (1997) 1.39
Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev (2003) 1.37
Quantification of power Doppler energy and its future potential. Fertil Steril (2001) 1.35
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34
Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol (2000) 1.34
Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol (1996) 1.30
Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol (1995) 1.29
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes (1999) 1.28
Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract (2003) 1.27
Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int (2001) 1.26
Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol (2000) 1.25
Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest (1990) 1.25
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. Kidney Int (2006) 1.24
Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.24
Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium (2008) 1.23
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis (1999) 1.21
Exenatide versus glibenclamide in patients with diabetes. Diabetes Technol Ther (2010) 1.21
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia (2006) 1.20
Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis (2002) 1.19
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol (2001) 1.17
Familiarity and recollection in item and associative recognition. Mem Cognit (1999) 1.15
Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ (1994) 1.15
The metabolic syndrome is related to albuminuria in Type 2 diabetes. Diabet Med (2008) 1.14
Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab (1999) 1.14
Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol (2005) 1.14
Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci (1999) 1.14
FIRI: fasting or false insulin resistance index? Lancet (1996) 1.13
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology (1996) 1.12
Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology. Nutr Metab Cardiovasc Dis (2012) 1.12
Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance. Diabetologia (2003) 1.12
Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes (2000) 1.10
Platelets and the vessel wall: how much aspirin? Lancet (1980) 1.09
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer (2000) 1.09
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. Oncogene (2001) 1.09
Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation (1998) 1.08
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med (1995) 1.08
Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J (2001) 1.08
Monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for the measurement of vitamin K-dependent protein S: the effect of antibody immunoreactivity on plasma protein S antigen determinations. Thromb Haemost (1992) 1.08
Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? Eur J Clin Nutr (2007) 1.07
Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome. Am J Kidney Dis (2001) 1.07
Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab (2000) 1.07
Differential regulation of intracellular glucose metabolism by glucose and insulin in human muscle. Am J Physiol (1993) 1.06
Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Int J Clin Pract (2005) 1.06
Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest (2000) 1.05